FourThought Financial Partners LLC Purchases Shares of 2,218 Intuitive Surgical, Inc. (NASDAQ:ISRG)

FourThought Financial Partners LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,218 shares of the medical equipment provider's stock, valued at approximately $1,158,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Howard Capital Management Group LLC boosted its holdings in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock worth $1,044,000 after acquiring an additional 92 shares during the period. Mount Yale Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $225,000. NorthCrest Asset Manangement LLC boosted its stake in shares of Intuitive Surgical by 20.6% in the third quarter. NorthCrest Asset Manangement LLC now owns 1,701 shares of the medical equipment provider's stock valued at $836,000 after buying an additional 291 shares during the period. GHP Investment Advisors Inc. grew its position in Intuitive Surgical by 1,287.5% during the third quarter. GHP Investment Advisors Inc. now owns 111 shares of the medical equipment provider's stock worth $55,000 after buying an additional 103 shares in the last quarter. Finally, Capital Advisors Ltd. LLC raised its holdings in Intuitive Surgical by 31.9% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 124 shares of the medical equipment provider's stock valued at $61,000 after acquiring an additional 30 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 408 shares of the business's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company's stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,240 shares of company stock valued at $3,529,040. Corporate insiders own 0.80% of the company's stock.

Intuitive Surgical Stock Performance

ISRG traded down $17.27 during midday trading on Tuesday, reaching $573.74. 2,548,276 shares of the company were exchanged, compared to its average volume of 1,739,679. The company has a market cap of $204.35 billion, a price-to-earnings ratio of 89.51, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company's fifty day moving average price is $566.43 and its 200 day moving average price is $526.49.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Piper Sandler reissued an "overweight" rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Truist Financial lifted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a report on Friday, January 24th. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.